Literature DB >> 34183391

IgA potentiates NETosis in response to viral infection.

Hannah D Stacey1,2,3, Diana Golubeva1,2,3, Alyssa Posca1,2,3, Jann C Ang1,2,3, Kyle E Novakowski1,2,4, Muhammad Atif Zahoor2,4, Charu Kaushic2,4, Ewa Cairns5,6, Dawn M E Bowdish1,2,4, Caitlin E Mullarkey1, Matthew S Miller7,2,3.   

Abstract

IgA is the second most abundant antibody present in circulation and is enriched at mucosal surfaces. As such, IgA plays a key role in protection against a variety of mucosal pathogens including viruses. In addition to neutralizing viruses directly, IgA can also stimulate Fc-dependent effector functions via engagement of Fc alpha receptors (Fc-αRI) expressed on the surface of certain immune effector cells. Neutrophils are the most abundant leukocyte, express Fc-αRI, and are often the first to respond to sites of injury and infection. Here, we describe a function for IgA-virus immune complexes (ICs) during viral infections. We show that IgA-virus ICs potentiate NETosis-the programmed cell-death pathway through which neutrophils release neutrophil extracellular traps (NETs). Mechanistically, IgA-virus ICs potentiated a suicidal NETosis pathway via engagement of Fc-αRI on neutrophils through a toll-like receptor-independent, NADPH oxidase complex-dependent pathway. NETs also were capable of trapping and inactivating viruses, consistent with an antiviral function.

Entities:  

Keywords:  NETosis; SARS-CoV-2; influenza; neutrophils; viruses

Mesh:

Substances:

Year:  2021        PMID: 34183391      PMCID: PMC8271757          DOI: 10.1073/pnas.2101497118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  60 in total

Review 1.  Antibody-dependent cellular cytotoxicity in HIV infection.

Authors:  Donald N Forthal; Andrés Finzi
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

2.  Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.

Authors:  Wenqian He; Caitlin E Mullarkey; J Andrew Duty; Thomas M Moran; Peter Palese; Matthew S Miller
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

3.  High Level of Neutrophil Extracellular Traps Correlates With Poor Prognosis of Severe Influenza A Infection.

Authors:  Liuluan Zhu; Lu Liu; Yue Zhang; Lin Pu; Jingyuan Liu; Xingwang Li; Zhihai Chen; Yu Hao; Beibei Wang; Junyan Han; Guoli Li; Shuntao Liang; Haofeng Xiong; Hong Zheng; Ang Li; Jianqing Xu; Hui Zeng
Journal:  J Infect Dis       Date:  2018-01-17       Impact factor: 5.226

4.  Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.

Authors:  Balaji Manicassamy; Rafael A Medina; Rong Hai; Tshidi Tsibane; Silke Stertz; Estanislao Nistal-Villán; Peter Palese; Christopher F Basler; Adolfo García-Sastre
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

5.  Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.

Authors:  Andrew B Herr; Edward R Ballister; Pamela J Bjorkman
Journal:  Nature       Date:  2003-05-21       Impact factor: 49.962

Review 6.  The multifactorial role of neutrophils in rheumatoid arthritis.

Authors:  Helen L Wright; Robert J Moots; Steven W Edwards
Journal:  Nat Rev Rheumatol       Date:  2014-06-10       Impact factor: 20.543

7.  Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis.

Authors:  Teluguakula Narasaraju; Edwin Yang; Ramar Perumal Samy; Huey Hian Ng; Wee Peng Poh; Audrey-Ann Liew; Meng Chee Phoon; Nico van Rooijen; Vincent T Chow
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

8.  Novel cell death program leads to neutrophil extracellular traps.

Authors:  Tobias A Fuchs; Ulrike Abed; Christian Goosmann; Robert Hurwitz; Ilka Schulze; Volker Wahn; Yvette Weinrauch; Volker Brinkmann; Arturo Zychlinsky
Journal:  J Cell Biol       Date:  2007-01-08       Impact factor: 10.539

9.  Virus-induced NETs--critical component of host defense or pathogenic mediator?

Authors:  Craig N Jenne; Paul Kubes
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

Review 10.  A Role for Neutrophils in Viral Respiratory Disease.

Authors:  Jeremy V Camp; Colleen B Jonsson
Journal:  Front Immunol       Date:  2017-05-12       Impact factor: 7.561

View more
  11 in total

Review 1.  Neutrophil Functional Heterogeneity and Implications for Viral Infections and Treatments.

Authors:  Lily Chan; Solmaz Morovati; Negar Karimi; Kasra Alizadeh; Sierra Vanderkamp; Julia E Kakish; Byram W Bridle; Khalil Karimi
Journal:  Cells       Date:  2022-04-13       Impact factor: 7.666

Review 2.  Neutrophils and Influenza: A Thin Line between Helpful and Harmful.

Authors:  Sneha T George; Jonathan Lai; Julia Ma; Hannah D Stacey; Matthew S Miller; Caitlin E Mullarkey
Journal:  Vaccines (Basel)       Date:  2021-06-04

Review 3.  Receptor-Mediated NETosis on Neutrophils.

Authors:  Tao Chen; Yanhong Li; Rui Sun; Huifang Hu; Yi Liu; Martin Herrmann; Yi Zhao; Luis E Muñoz
Journal:  Front Immunol       Date:  2021-11-04       Impact factor: 7.561

4.  B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination.

Authors:  Prasanti Kotagiri; Federica Mescia; William M Rae; Laura Bergamaschi; Zewen K Tuong; Lorinda Turner; Kelvin Hunter; Pehuén P Gerber; Myra Hosmillo; Christoph Hess; Menna R Clatworthy; Ian G Goodfellow; Nicholas J Matheson; Eoin F McKinney; Mark R Wills; Ravindra K Gupta; John R Bradley; Rachael J M Bashford-Rogers; Paul A Lyons; Kenneth G C Smith
Journal:  Cell Rep       Date:  2022-01-31       Impact factor: 9.423

5.  Inactivated and live-attenuated seasonal influenza vaccines boost broadly neutralizing antibodies in children.

Authors:  Sergey Yegorov; Daniel B Celeste; Kimberly Braz Gomes; Jann C Ang; Colin Vandenhof; Joanne Wang; Ksenia Rybkina; Vanessa Tsui; Hannah D Stacey; Mark Loeb; Matthew S Miller
Journal:  Cell Rep Med       Date:  2022-02-03

Review 6.  Leveraging Antibody, B Cell and Fc Receptor Interactions to Understand Heterogeneous Immune Responses in Tuberculosis.

Authors:  Stephen M Carpenter; Lenette L Lu
Journal:  Front Immunol       Date:  2022-03-17       Impact factor: 7.561

7.  Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2.

Authors:  Sam Afkhami; Michael R D'Agostino; Ali Zhang; Hannah D Stacey; Art Marzok; Alisha Kang; Ramandeep Singh; Jegarubee Bavananthasivam; Gluke Ye; Xiangqian Luo; Fuan Wang; Jann C Ang; Anna Zganiacz; Uma Sankar; Natallia Kazhdan; Joshua F E Koenig; Allyssa Phelps; Steven F Gameiro; Shangguo Tang; Manel Jordana; Yonghong Wan; Karen L Mossman; Mangalakumari Jeyanathan; Amy Gillgrass; Maria Fe C Medina; Fiona Smaill; Brian D Lichty; Matthew S Miller; Zhou Xing
Journal:  Cell       Date:  2022-02-09       Impact factor: 66.850

Review 8.  Role of Extracellular Trap Release During Bacterial and Viral Infection.

Authors:  Bárbara M Schultz; Orlando A Acevedo; Alexis M Kalergis; Susan M Bueno
Journal:  Front Microbiol       Date:  2022-01-26       Impact factor: 5.640

9.  Eugenol alleviates transmissible gastroenteritis virus-induced intestinal epithelial injury by regulating NF-κB signaling pathway.

Authors:  Kang Wang; Daiwen Chen; Bing Yu; Jun He; Xiangbing Mao; Zhiqing Huang; Hui Yan; Aimin Wu; Yuheng Luo; Ping Zheng; Jie Yu; Junqiu Luo
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

10.  Hemagglutinin stalk-binding antibodies enhance effectiveness of neuraminidase inhibitors against influenza via Fc-dependent effector functions.

Authors:  Ali Zhang; Hanu Chaudhari; Yonathan Agung; Michael R D'Agostino; Jann C Ang; Yona Tugg; Matthew S Miller
Journal:  Cell Rep Med       Date:  2022-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.